Vaxelis Injection, Suspension
Product Images NDC 63361-243

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Vaxelis (NDC 63361-243). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Msp Vaccine Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (0.5 mL Vial Label)

Label for Vaxelis, a vaccine injection suspension containing diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, haemophilus b conjugate, and hepatitis b vaccine. The single-dose vial (0.5 mL) is indicated for intramuscular use in children 6 weeks to 4 years. The label shows NDC 63361-243-58 and is manufactured by Sanofi Pasteur Limited.*

FDA Label Image

Principal Display Panel (10 Vial Package)

Packaging label for VAXELIS, a vaccine injection suspension for intramuscular use, containing diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, haemophilus b conjugate, and hepatitis b vaccine. The label shows a box for 10 single-dose vials, manufactured by Sanofi Pasteur Limited and labeled by MSP Vaccine Company. The label includes dosage and storage instructions, barcode, NDC 63361-243-10, and branding from MSP Vaccine Company and Merck.*

FDA Label Image

Vaxelis 03

VAXELIS vaccine label showing the product name and its full generic description as a diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, haemophilus b conjugate and hepatitis b vaccine. It specifies a single-dose 0.5 mL intramuscular injection for ages 6 weeks to 4 years. The label also includes the NDC 63361-243-88 and notes it is manufactured by Sanofi Pasteur Limited.*

FDA Label Image

Vaxelis 04

VAXELIS DTaP-IPV-Hib-HepB vaccine carton label for 10 single-dose prefilled syringes. Contains diphtheria and tetanus toxoids, acellular pertussis, inactivated poliovirus, Haemophilus b conjugate, and hepatitis B vaccine. Injection suspension for intramuscular use, distributed by Merck and manufactured by Sanofi Pasteur and MSP Vaccine Company. Storage instructions and detailed ingredient contents are included on the packaging.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.